90 related articles for article (PubMed ID: 17229489)
1. Neuropeptide Y (NPY) in neuroblastoma: effect on growth and vascularization.
Kitlinska J
Peptides; 2007 Feb; 28(2):405-12. PubMed ID: 17229489
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors.
Kitlinska J; Abe K; Kuo L; Pons J; Yu M; Li L; Tilan J; Everhart L; Lee EW; Zukowska Z; Toretsky JA
Cancer Res; 2005 Mar; 65(5):1719-28. PubMed ID: 15753367
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y in neural crest-derived tumors: effect on growth and vascularization.
Kitlinska J
Cancer Lett; 2007 Jan; 245(1-2):293-302. PubMed ID: 16513255
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.
Lu C; Everhart L; Tilan J; Kuo L; Sun CC; Munivenkatappa RB; Jönsson-Rylander AC; Sun J; Kuan-Celarier A; Li L; Abe K; Zukowska Z; Toretsky JA; Kitlinska J
Oncogene; 2010 Oct; 29(41):5630-42. PubMed ID: 20676138
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology.
Tilan J; Kitlinska J
Neuropeptides; 2016 Feb; 55():55-66. PubMed ID: 26549645
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles.
Lee EW; Michalkiewicz M; Kitlinska J; Kalezic I; Switalska H; Yoo P; Sangkharat A; Ji H; Li L; Michalkiewicz T; Ljubisavljevic M; Johansson H; Grant DS; Zukowska Z
J Clin Invest; 2003 Jun; 111(12):1853-62. PubMed ID: 12813021
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.
Czarnecka M; Trinh E; Lu C; Kuan-Celarier A; Galli S; Hong SH; Tilan JU; Talisman N; Izycka-Swieszewska E; Tsuei J; Yang C; Martin S; Horton M; Christian D; Everhart L; Maheswaran I; Kitlinska J
Oncogene; 2015 Jun; 34(24):3131-43. PubMed ID: 25132261
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.
Galli S; Naranjo A; Van Ryn C; Tilan JU; Trinh E; Yang C; Tsuei J; Hong SH; Wang H; Izycka-Swieszewska E; Lee YC; Rodriguez OC; Albanese C; Kitlinska J
Am J Pathol; 2016 Nov; 186(11):3040-3053. PubMed ID: 27743558
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors.
Movafagh S; Hobson JP; Spiegel S; Kleinman HK; Zukowska Z
FASEB J; 2006 Sep; 20(11):1924-6. PubMed ID: 16891622
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
Medeiros PJ; Jackson DN
Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
[TBL] [Abstract][Full Text] [Related]
11. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
[TBL] [Abstract][Full Text] [Related]
12. Plasma neuropeptide Y of children with neuroblastoma in relation to stage, age and prognosis, and tissue neuropeptide Y.
Dötsch J; Christiansen H; Hänze J; Lampert F; Rascher W
Regul Pept; 1998 Sep; 75-76():185-90. PubMed ID: 9802408
[TBL] [Abstract][Full Text] [Related]
13. Functional expression of neuropeptide Y receptors in human neuroblastoma cells.
Li AJ; Ritter S
Regul Pept; 2005 Jul; 129(1-3):119-24. PubMed ID: 15927706
[TBL] [Abstract][Full Text] [Related]
14. Stress, NPY and vascular remodeling: Implications for stress-related diseases.
Kuo LE; Abe K; Zukowska Z
Peptides; 2007 Feb; 28(2):435-40. PubMed ID: 17241699
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas.
Hecht M; Papoutsi M; Tran HD; Wilting J; Schweigerer L
Cancer Res; 2004 Sep; 64(17):6109-18. PubMed ID: 15342394
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of neuropeptide Y-mediated calcium responses in human SMS-KAN neuroblastoma cells endogenously expressing Y2 receptors by co-expression of chimeric G proteins.
Dautzenberg FM
Biochem Pharmacol; 2005 May; 69(10):1493-9. PubMed ID: 15857613
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?
Zukowska Z; Pons J; Lee EW; Li L
Can J Physiol Pharmacol; 2003 Feb; 81(2):89-94. PubMed ID: 12710520
[TBL] [Abstract][Full Text] [Related]
18. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
Henry M; Ghibaudi L; Gao J; Hwa JJ
Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells.
Connor M; Yeo A; Henderson G
Br J Pharmacol; 1997 Feb; 120(3):455-63. PubMed ID: 9031749
[TBL] [Abstract][Full Text] [Related]
20. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
